AllNewsVideos'Novartis Drug' - 108 News Result(s)Novartis Pharma Signs World's 1st Licensing Deal For Cancer DrugWorld News | Agence France-Presse | Thursday October 20, 2022 Pharmaceutical giant Novartis has signed a licensing agreement increasing access to a vital leukaemia treatment, a UN-backed public health organisation said Thursday, marking the first-ever such agreement for a cancer drug. www.ndtv.comHigh Court Restrains Generic Pharma Firms From Making, Selling Patent Drug Of NovartisIndia News | Press Trust of India | Tuesday November 2, 2021 The Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or selling Valsartan and Sacubitril tablets, a combination to treat cardiovascular diseases, as it may amount to infringement of patent of pharma major www.ndtv.comGujarat Couple Raise Rs 16 Crore For 1 Injection To Save 5-Month-Old SonIndia News | Press Trust of India | Wednesday May 5, 2021 A couple from Gujarat has raised Rs 16 crore with the help of a crowdfunding platform to buy a gene therapy injection for the treatment of their 5-month-old son suffering from spinal muscular atrophy, a rare genetic disorder. www.ndtv.comNovartis Sickle-Cell Drug Gets US ApprovalBusiness | Reuters | Saturday November 16, 2019 The drug will be priced between $84,852 and $113,136 per year for most patients, who will typically infuse themselves with between three and four vials each month, Novartis said. www.ndtv.com/businessJust Approved Gene Therapy Drug Is World's Most Expensive At $2.1 MillionWorld News | Christopher Rowland, The Washington Post | Saturday May 25, 2019 The Food and Drug Administration on Friday approved the most expensive drug in the world, a $2.1 million, one-time gene therapy for treatment of a rare disease that afflicts infants. www.ndtv.comAurobindo Pharma Buys Parts Of Sandoz US From Novartis For $900 MillionBusiness | Thomson Reuters | Thursday September 6, 2018 Novartis AG said on Thursday it would sell the dermatology and generic US oral solids portfolios of Sandoz US to Aurobindo Pharma Ltd for $900 million, as the Swiss drug maker looks to focus on higher growth areas. The deal also includes about 300 products and additional development projects of Sandoz and an additional $100 million in performance... www.ndtv.com/businessSwiss Pharmaceutical Giant Novartis To Inject $100 Million Into New Treatments For MalariaWorld News | Agence France-Presse | Tuesday April 17, 2018 Swiss pharmaceutical giant Novartis on Tuesday announced $100 million of funding over the next five years for research into new treatments for malaria, a mosquito-borne disease with a devastating impact that killed 445,000 people in 2016. www.ndtv.comIndia-Origin Vasant Narasimhan Named CEO Of NovartisBusiness | NDTV Profit Team | Monday September 4, 2017 Vasant Narasimhan is among a new generation of leaders at Novartis who have sought to improve the process in which drugs move from research to actually becoming a commercial product. www.ndtv.com/businessCipla, Wockhardt, Other Drug Makers Pledge To Clean Up Antibiotic FactoriesBusiness | Thomson Reuters | Tuesday September 20, 2016 Thirteen leading drug makers promised on Tuesday to clean up pollution from factories making antibiotics and take steps to curb overuse of the medicines as part of a drive to fight the rise of drug-resistant superbugs. www.ndtv.com/businessEuropean Advisory Panel Recommends Nod For Pfizer Breast Cancer DrugBusiness | Reuters | Friday September 16, 2016 US drug maker Pfizer Inc's breast cancer drug, Ibrance, should be given marketing approval, an advisory committee at the European Medicines Agency recommended. www.ndtv.com/businessSun Pharma Inks Distribution Alliance With Mitsubishi TanabeBusiness | Press Trust of India | Tuesday September 6, 2016 Drug major Sun Pharma has announced initiation of a phased transfer of manufacturing and marketing rights of 14 brands, it acquired from Swiss drug firm Novartis in Japan, earlier this year for $293 million. www.ndtv.com/businessCompound Found To Treat 3 Parasitic Tropical DiseasesWorld News | Reuters | Tuesday August 9, 2016 In a study published in the journal Nature, scientists at the Genomics Institute of the Novartis Research Foundation found the compound can cure all three diseases in mice, and does not harm normal human cells in laboratory tests. www.ndtv.comNovartis India Q1 Net Profit At Rs 19 CroreBusiness | Press Trust of India | Thursday July 28, 2016 Drug firm Novartis India reported a standalone net profit of Rs 19.07 crore for the first quarter ended June 30, 2016. www.ndtv.com/businessNovartis Slumps On Q4 Result DisappointmentBusiness | Press Trust of India | Friday May 27, 2016 Shares of drug firm Novartis India on Friday slumped 13 per cent on disappointment over the company's earnings for the quarter ended March 2016. www.ndtv.com/businessNovartis Posts Rs 22 Crore Profit In Q4Business | Press Trust of India | Thursday May 26, 2016 Drug firm Novartis India on Thursday reported a standalone net profit of Rs 21.53 crore for the quarter ended March 31, 2016. www.ndtv.com/businessMore News »'Novartis Drug' - 9 Video Result(s)Drug Price Cap to Impact Glaxo, Sanofi, Novartis most: Prabhudas LilladherJul 15, 201410:28Novartis verdict fallout: Patents vs patients?Apr 6, 201350:44Novartis ruling shows India doesn't want innovation: Peter PittsApr 3, 20133:55The 9 O'clock News: The biggest stories (April 2, 2013)Apr 2, 201350:15Patent war: patients vs profit?Apr 2, 201335:39Money Mantra: Analysis Supreme Court’s verdict on NovartisApr 2, 201350:02Supreme Court backs generics in Novartis drug patent rulingApr 1, 20132:23Supreme Court denies Novartis patent for cancer drugApr 1, 201320:01GSK to sell animal healthcare businessMar 6, 20060:00'Novartis Drug' - 108 News Result(s)Novartis Pharma Signs World's 1st Licensing Deal For Cancer DrugWorld News | Agence France-Presse | Thursday October 20, 2022 Pharmaceutical giant Novartis has signed a licensing agreement increasing access to a vital leukaemia treatment, a UN-backed public health organisation said Thursday, marking the first-ever such agreement for a cancer drug. www.ndtv.comHigh Court Restrains Generic Pharma Firms From Making, Selling Patent Drug Of NovartisIndia News | Press Trust of India | Tuesday November 2, 2021 The Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or selling Valsartan and Sacubitril tablets, a combination to treat cardiovascular diseases, as it may amount to infringement of patent of pharma major www.ndtv.comGujarat Couple Raise Rs 16 Crore For 1 Injection To Save 5-Month-Old SonIndia News | Press Trust of India | Wednesday May 5, 2021 A couple from Gujarat has raised Rs 16 crore with the help of a crowdfunding platform to buy a gene therapy injection for the treatment of their 5-month-old son suffering from spinal muscular atrophy, a rare genetic disorder. www.ndtv.comNovartis Sickle-Cell Drug Gets US ApprovalBusiness | Reuters | Saturday November 16, 2019 The drug will be priced between $84,852 and $113,136 per year for most patients, who will typically infuse themselves with between three and four vials each month, Novartis said. www.ndtv.com/businessJust Approved Gene Therapy Drug Is World's Most Expensive At $2.1 MillionWorld News | Christopher Rowland, The Washington Post | Saturday May 25, 2019 The Food and Drug Administration on Friday approved the most expensive drug in the world, a $2.1 million, one-time gene therapy for treatment of a rare disease that afflicts infants. www.ndtv.comAurobindo Pharma Buys Parts Of Sandoz US From Novartis For $900 MillionBusiness | Thomson Reuters | Thursday September 6, 2018 Novartis AG said on Thursday it would sell the dermatology and generic US oral solids portfolios of Sandoz US to Aurobindo Pharma Ltd for $900 million, as the Swiss drug maker looks to focus on higher growth areas. The deal also includes about 300 products and additional development projects of Sandoz and an additional $100 million in performance... www.ndtv.com/businessSwiss Pharmaceutical Giant Novartis To Inject $100 Million Into New Treatments For MalariaWorld News | Agence France-Presse | Tuesday April 17, 2018 Swiss pharmaceutical giant Novartis on Tuesday announced $100 million of funding over the next five years for research into new treatments for malaria, a mosquito-borne disease with a devastating impact that killed 445,000 people in 2016. www.ndtv.comIndia-Origin Vasant Narasimhan Named CEO Of NovartisBusiness | NDTV Profit Team | Monday September 4, 2017 Vasant Narasimhan is among a new generation of leaders at Novartis who have sought to improve the process in which drugs move from research to actually becoming a commercial product. www.ndtv.com/businessCipla, Wockhardt, Other Drug Makers Pledge To Clean Up Antibiotic FactoriesBusiness | Thomson Reuters | Tuesday September 20, 2016 Thirteen leading drug makers promised on Tuesday to clean up pollution from factories making antibiotics and take steps to curb overuse of the medicines as part of a drive to fight the rise of drug-resistant superbugs. www.ndtv.com/businessEuropean Advisory Panel Recommends Nod For Pfizer Breast Cancer DrugBusiness | Reuters | Friday September 16, 2016 US drug maker Pfizer Inc's breast cancer drug, Ibrance, should be given marketing approval, an advisory committee at the European Medicines Agency recommended. www.ndtv.com/businessSun Pharma Inks Distribution Alliance With Mitsubishi TanabeBusiness | Press Trust of India | Tuesday September 6, 2016 Drug major Sun Pharma has announced initiation of a phased transfer of manufacturing and marketing rights of 14 brands, it acquired from Swiss drug firm Novartis in Japan, earlier this year for $293 million. www.ndtv.com/businessCompound Found To Treat 3 Parasitic Tropical DiseasesWorld News | Reuters | Tuesday August 9, 2016 In a study published in the journal Nature, scientists at the Genomics Institute of the Novartis Research Foundation found the compound can cure all three diseases in mice, and does not harm normal human cells in laboratory tests. www.ndtv.comNovartis India Q1 Net Profit At Rs 19 CroreBusiness | Press Trust of India | Thursday July 28, 2016 Drug firm Novartis India reported a standalone net profit of Rs 19.07 crore for the first quarter ended June 30, 2016. www.ndtv.com/businessNovartis Slumps On Q4 Result DisappointmentBusiness | Press Trust of India | Friday May 27, 2016 Shares of drug firm Novartis India on Friday slumped 13 per cent on disappointment over the company's earnings for the quarter ended March 2016. www.ndtv.com/businessNovartis Posts Rs 22 Crore Profit In Q4Business | Press Trust of India | Thursday May 26, 2016 Drug firm Novartis India on Thursday reported a standalone net profit of Rs 21.53 crore for the quarter ended March 31, 2016. www.ndtv.com/businessMore News »'Novartis Drug' - 9 Video Result(s)Drug Price Cap to Impact Glaxo, Sanofi, Novartis most: Prabhudas LilladherJul 15, 201410:28Novartis verdict fallout: Patents vs patients?Apr 6, 201350:44Novartis ruling shows India doesn't want innovation: Peter PittsApr 3, 20133:55The 9 O'clock News: The biggest stories (April 2, 2013)Apr 2, 201350:15Patent war: patients vs profit?Apr 2, 201335:39Money Mantra: Analysis Supreme Court’s verdict on NovartisApr 2, 201350:02Supreme Court backs generics in Novartis drug patent rulingApr 1, 20132:23Supreme Court denies Novartis patent for cancer drugApr 1, 201320:01GSK to sell animal healthcare businessMar 6, 20060:00Your search did not match any documentsA few suggestionsMake sure all words are spelled correctlyTry different keywordsTry more general keywordsCheck the NDTV Archives:https://archives.ndtv.com